A scaleable route to the pure enantiomers of verapamil

Organic Process Research and Development

Volumn 4, Issue 6, 2000, Pages 467-472

  Bannister, Robin M ^a   Brookes, Michael H ^a   Evans, Graham R ^a   Katz, Ruth B ^a   Tyrrell, Nicholas D ^a  

^a UCB PHARMA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0034345895     PISSN: 10836160     EISSN: None     Source Type: Journal    
DOI: 10.1021/op000059q     Document Type: Article

References (23)

1. Cervoni, P.; Crandall, D. L.; Chan, P. S. Cardiovascular Agents. In Kirk-Othmer Encyclopedia of Chemical Technology, 4th ed.; Kroschwitz, J. L., Executive Ed.; Howe-Grant, M., Ed.; Wiley: New York, 1992; Vol. 5, pp 207-300 and references therein.
2. Longstreth, J. A. Verapamil: A Chiral Challenge to the Pharmacokinetic and Pharmacodynamic Assessment of Bioavailability and Bioequivalence. In Clinical Pharmacology, 2nd ed.; Wainer, I. W., Drayer, D. E., Eds.; Drug Stereochemistry, Vol. 11; Dekker: New York, 1993; p 315.
3. Eliason, J. F.; Ramuz H.; and Kaufmann, F. Int. J. Cancer. 1990, 46, 113.
4. Peroutka, S. J. Ann. Neurol. 1988, 23, 500.
5. Longstreth, J. A.; Fakhreddin, J. Int. Patent Appl. W09744025A1 (U.S. Patent 5,955,500, 1999).
6. Ramuz, H. Helv. Chim. Acta. 1975, 58, 2050.
7. Theodore, L. J.; Nelson, W. L. J. Org. Chem. 1987, 52, 1309.
8. Gilmore, J.; Prowse, W.; Steggles, D.; Urquhart, M.; Olkowski J. J. Chem. Soc., Perkin Trans. I 1996, 2845.
9. Blasche, G.; Doebber, P. Ger. Patent DE 3723684.
10. Ehrmann, O.; Nagel, H.; Karau, W. Int. Patent Appl. WO9316035 and WO9408950.
11. Dengel, F. Belg. Paient 615,861, 1962 ; Idem. U.S. Patent, 3,261,859, 1966.
12. Dengel, F. Belg. Paient 615,861, 1962 ; Idem. U.S. Patent, 3,261,859, 1966.
13. McCague, R.; Wang, S. Int. Patent Appl. WO 9509150.
14. Trieber, E. J.; Raschack M.; and Dengel, F. Ger. Patent 2,059,923, 1972 .
15. Fogassy, E.; Lopata, A.; Faigl, F.; Darvas, F.; Acs, M.; Toke, L.; Tetrahedron Lett. 1980, 21, 647.
16. Kastner, G.; Hardo, S.; Geiss, K. H. U.S. Patent 4,350,636, 1982.
17. Bannister, R. M.; Evans, G. R.; Skead, B. M. Int. Patent Appl. WO 9729081.
18. Ishihara, K.; Ohara, S.; Yamamoto, H. J. Org. Chem. 1996, 61, 4196.
19. Pelter, A.; Smith, K.; Brown, H. C. In Borane Reagents; Katritsky, R.; Meth-Cohn, O.; Rees, C. W. Eds.; Academic: San Diego, 1988.
20. Seyden-Penne, J. Reductions by the Alumino-and Borohydrides in Organic Synthesis; VCH: New York, 1991.
21. For a thorough review on analytical topics related to verapamil see: Chang, Z. L. Analytical Profiles of Drug Substances 1988, 17, 643.
22. McCague, R. International Patent Appl. WO 9729080.
23. The physical yields quoted are net of the quantity of authentic seed added.